Fasudil inhibits LPS-induced migration of retinal microglial cells via regulating p38-MAPK signaling pathway

Mol Vis. 2016 Jul 19:22:836-46. eCollection 2016.

Abstract

Purpose: To investigate the effect and possible molecular mechanisms of fasudil on retinal microglial (RMG) cell migration.

Methods: Primary cultured RMG cells were incubated with lipopolysaccharide (LPS), fasudil, and/or SB203580 (a p38 inhibitor). RMG cell motility was determined with the scratch wound assay and the Transwell migration assay. The phosphorylation of p38 and levels of matrix metalloproteinase 2 (MMP-2) and MMP-9 were measured with western blot.

Results: In the scratch-induced migration assay, as well as in the Transwell migration assay, the results indicated that LPS stimulated the migratory potential of RMG cells and fasudil significantly reduced LPS-stimulated RMG cell migration in a concentration-dependent manner. However, fasudil had no effect on RMG cell migration in the absence of LPS stimulation. Moreover, fasudil reduced the level of phosphor-p38 mitogen-activated protein kinase (p-p38-MAPK) in a concentration-dependent manner, without effects on the levels of phospho-p44/42 (p-ERK1/2) and phospho-c-Jun N-terminal kinase (p-JNK). Cotreatment with SB203580 (a p38 inhibitor) and fasudil resulted in the synergistic reduction of MMP-2, MMP-9, and p-p38-MAPK, as well as a reduction in the LPS-stimulated migration capabilities of the RMG cells, suggesting fasudil suppresses the LPS-stimulated migration of RMG cells via directly downregulating the p38-MAPK signaling pathway.

Conclusions: Our studies indicated that fasudil inhibited LPS-stimulated RMG cell migration via suppression of the p38-MAPK signaling pathway.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives*
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Animals
  • Animals, Newborn
  • Blotting, Western
  • Cell Movement / drug effects*
  • Cell Proliferation
  • Dose-Response Relationship, Drug
  • Imidazoles / pharmacology
  • Lipopolysaccharides / antagonists & inhibitors*
  • Lipopolysaccharides / pharmacology
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Microglia / drug effects
  • Microglia / metabolism
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology*
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Retinal Neurons / drug effects*
  • Retinal Neurons / metabolism
  • Signal Transduction / physiology*
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Imidazoles
  • Lipopolysaccharides
  • Protein Kinase Inhibitors
  • Pyridines
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • p38 Mitogen-Activated Protein Kinases
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • SB 203580
  • fasudil